Rosa María Hernandez obtained her PhD in Pharmacy at the Univesity of Salamanca in 1992.
In 1993, Dr. Hernandez moved to University of the Basque Country (UPV/EHU) . Professor since 2009. She is Principal Investigator in several research projects and has supervised 20 PhD thesis works and co-authored more than 200 scientific articles and 10 patents. h-index: 43 Scopus, 52 Google Scholar). Her research fields focus on severa areas of drug delivery including micro- and nanoencapsulation of peptides and proteins as vaccine delivery systems, encapsulation of growth factors as an alternative therapy for Parkinson or Alzheimer’s diseases and cell based therapies for regenerative medicine.
Rosa María Hernandez obtained her PhD in Pharmacy at the Univesity of Salamanca in 1992.
In 1993, Dr. Hernandez moved to University of the Basque Country (UPV/EHU) . Professor since 2009. She is Principal Investigator in several research projects and has supervised 20 PhD thesis works and co-authored more than 200 scientific articles and 10 patents. h-index: 43 Scopus, 52 Google Scholar). Her research fields focus on severa areas of drug delivery including micro- and nanoencapsulation of peptides and proteins as vaccine delivery systems, encapsulation of growth factors as an alternative therapy for Parkinson or Alzheimer’s diseases and cell based therapies for regenerative medicine.